We analyze lepton flavour violation (LFV), as well as generation of the observed baryon-antibaryon asymmetry of the Universe (BAU) within a generalized minimal lepton flavour violation (MLFV) framework where we allow for CP violation both at low and high energies. The generation of BAU is obtained through radiative resonant leptogenesis (RRL), where starting with three exactly degenerate right-handed neutrinos at Λ GUT , we demonstrate explicitly within the SM and the MSSM that the splittings between their masses at the see-saw scale M ν , generated by renormalization group effects, are sufficient for a successful leptogenesis for M ν even as low as 10 6 GeV. The inclusion of flavour effects plays an important role in this result and can lead to the observed BAU even in the absence of CP violation beyond the PMNS phases. The absence of a stringent lower bound on M ν in this type of leptogenesis allows to easily satisfy present and near future upper bounds on µ → eγ and other charged lepton flavour violating (LFV) processes even for Λ LFV = O(1 TeV). We find, that the MLFV framework in the presence of heavy righthanded neutrinos and leptogenesis is not as predictive as MFV in the quark sector and point out that without a specific MLFV model, there is a rich spectrum of possibilities for charged LFV processes and for their correlation with low energy neutrino physics and the LHC physics, even if the constraint from the observed BAU is taken into account. While certain qualitative features of our analysis confirm findings of Cirigliano et al., at the quantitative level we find phenomenologically important differences. We explain the origin of these differences.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.